529 Nonlinear pharmacokinetic modeling of XAA296 administered to patients with advanced solid tumors once every 3 weeks (q3w) intravenously (IV) in a phase I clinical trial

✍ Scribed by C. Hsu; T. Chen; A. Mita; A.C. Lockhart; M. Moricz; L. Alland; G. Taccard; E. Rowinsky; M.L. Rothenberg; S. Sharma

• Book ID: 118621711
• Publisher: Elsevier Science
• Year: 2004
• Tongue: English
• Weight: 140 KB
• Volume: 2
• Category: Article
• ISSN: 1359-6349
• DOI: 10.1016/s1359-6349(04)80537-8